Text Size

Provision of a Mobile Geriatric Team Extra-Community Hospital (UMG)

This study is currently recruiting participants.
Verified January 2013 by University Hospital, Grenoble
Sponsor:
Information provided by (Responsible Party):
AdministrateurCIC, University Hospital, Grenoble
ClinicalTrials.gov Identifier:
NCT01449968
First received: July 7, 2011
Last updated: January 8, 2013
Last verified: January 2013
History of Changes
  Purpose

The purpose of this study is to demonstrate the effectiveness of the mobile unit to reduce the geriatric hospital inappropriate (especially for emergencies) to 1 month.

The primary endpoint: survival without hospitalization through the emergency inappropriate to 1 month.


Condition Intervention
Geriatric Disorder
Mobil Unit
 Other: home visit
Other: telephone management of the mobile unit of Geriatrics

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Provision of a Mobile Geriatric Team Extra-Community Hospital in Assessing and Regulating the Hospitalization of Frail Elderly Patients With Complex Medical and Social Situation

Further study details as provided by University Hospital, Grenoble:

Primary Outcome Measures:
  • effectiveness of the visit of the mobile unit to reduce the geriatric hospital inappropriate (especially for emergencies) to 1 month [ Time Frame: 1 month ] [ Designated as safety issue: No ]
    inappropriate survival without hospitalization through the emergency room at 1 month


Secondary Outcome Measures:
  • follow-up rate of the proposals of UMG ext (adherence to recommendations and feasibility) and analyze the reasons for not monitoring these proposals one month [ Time Frame: 1 month ] [ Designated as safety issue: No ]
    follow-up of recommendations made by the mobile unit of Geriatrics

  • survival without hospitalization inappropriate, mortality, changes in functional status and cognitive health care consumption up to 6 months of surgery [ Time Frame: 6 months ] [ Designated as safety issue: No ]
    Unplanned hospitalization rates obtained by telephone follow-up at 3 and 6 months

  • effectiveness of the visit of the mobile geriatric home versus telephone follow-up of mobile geriatric unit [ Time Frame: 6 months ] [ Designated as safety issue: No ]
    Analysis of sub-groups

  • needs and difficulties of attending physicians in the care of frail elderly patients with complex medical and social situation before and after the establishment of mobile units for geriatrics. [ Time Frame: 1 year ] [ Designated as safety issue: No ]
    Questionnaire to GPs in the health sector concerned

  • cost effectiveness of two types of visit of the mobile unit of Geriatrics (telephone regulation and control over travel home phone) [ Time Frame: 6 months ] [ Designated as safety issue: No ]
    Cost of hospitalization.


Estimated Enrollment: 600
Study Start Date: June 2011
Estimated Study Completion Date: November 2013
Estimated Primary Completion Date: May 2013 (Final data collection date for primary outcome measure)
Groups/Cohorts Assigned Interventions
home visit of UMG
home visit with evaluation and management of the situation (control over in-home telephone)
 Other: home visit
home visit of UMG
telephone management
geriatric mobile unit provides a telephone advice only to the general practitioner with guidance and recommendations (call control)
 Other: telephone management of the mobile unit of Geriatrics
telephone management of the situation reported by the patient's GP

Detailed Description:

The purpose of this study is to assess the effectiveness of the Mobile Geriatrics on the management of complex situations in retirement homes and in ambulatory care of frail elderly patients, reported by the generalist doctor, in terms of improving the conditions of use technical support hospital follow-up recommendations given by the mobile team and their impact on outcomes of care.

  Eligibility

Ages Eligible for Study:   75 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

The study population includes patients over 75 years in medical condition or psycho-social complex, followed by a general practitioner to population centers include: Grenoble, Annecy and Roanne.

Criteria

Inclusion Criteria:

  • Patient aged 75 and over living in complex medical or psycho-social complex or at risk of hospitalization
  • Patient affiliated to social security or beneficiary of such a regime
  • Patient available for follow-up to 6 months with a caregiver or accompanying social duly appointed.

Exclusion Criteria:

  • Patient residing outside intervention sector
  • Life-threatening emergency (ambulance)
  • Lack of complexity of the situation, supported by routine care
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01449968

Contacts
Contact: Jean-Luc BOSSON, PUPH 33476765040 JLBosson@chu-grenoble.fr

Locations
France
CH Annecy Recruiting
Annecy, France, 74000
Contact: Moheb Bahman, PH     33450636087     bmohebkhosravi@ch-annecy.fr    
Principal Investigator: Moheb Bahman, PH            
Sub-Investigator: Laurence Tavernier, PH            
University Hospital of Grenoble Recruiting
Grenoble, France, 38000
Contact: Isabelle Lanièce, PH         ILaniece@chu-grenoble.fr    
Sub-Investigator: Isabelle Laniece, PH            
CH Roanne Recruiting
Roanne, France, 42300
Contact: Maurice Pourrot, PH     33477443144     maurice.pourrot@ch-roanne.fr    
Sub-Investigator: Valérie Lapouge Bard, PH            
Sponsors and Collaborators
University Hospital, Grenoble
Investigators
Principal Investigator: Pascal COUTURIER, PUPH Geriatric unit - University Hospital of Grenoble
  More Information

Publications:

Responsible Party: AdministrateurCIC, Pr Pascal COUTURIER, University Hospital, Grenoble, University Hospital, Grenoble
ClinicalTrials.gov Identifier: NCT01449968     History of Changes
Other Study ID Numbers: DCIC 10 16
Study First Received: July 7, 2011
Last Updated: January 8, 2013
Health Authority: France : Comité d'Ethique des Centres d'Investigation Clinique de l'inter-région Rhône-Alpes-Auvergne N°IRB 5891

ClinicalTrials.gov processed this record on May 19, 2013